Rankings
▼
Calendar
SAVA Q4 2018 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena
SAVA
Cassava Sciences, Inc.
$115M
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2
Operating Income
-$750,000
Net Income
-$677,000
EPS (Diluted)
$-0.04
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$565,000
Free Cash Flow
-$565,000
Stock-Based Comp.
$403,000
Balance Sheet
Total Assets
$20M
Total Liabilities
$511,000
Stockholders' Equity
$20M
Cash & Equivalents
$20M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2
-$1,544
+99.9%
Operating Income
-$750,000
-$2M
+69.0%
Net Income
-$677,000
-$2M
+72.0%
← FY 2018
All Quarters
Q1 2019 →